CION Ameerpet
Extranodal NK/T-cell lymphoma is a rare, aggressive non-Hodgkin lymphoma that usually starts in the nose and midline of the face and is closely tied to the Epstein-Barr virus. This guide explains what it is, how it is diagnosed, and how CION's team plans radiation- and chemotherapy-based care.
Extranodal NK/T-cell lymphoma is a rare, aggressive form of non-Hodgkin lymphoma. It develops from natural killer (NK) cells — a type of immune cell — or, less commonly, from true T-cells, which is why the name carries both. Because it usually begins in tissues rather than in lymph nodes, it is called "extranodal". The most common presentation, the nasal type, centres on the nose, sinuses and midline of the face.
A defining feature of this nasal lymphoma is its almost universal link to the Epstein-Barr virus (EBV) — the same common virus that causes glandular fever. EBV is found inside the tumour cells in nearly every case and helps confirm the diagnosis. This lymphoma sits within the wider T-cell lymphoma family but is treated as its own distinct entity because it behaves so differently from more common lymphomas.
This guide walks through the symptoms, how it is diagnosed, and how it is treated. For the full picture of lymphoma care, see our Lymphoma hub and our Lymphoma Treatment in Hyderabad page.
In extranodal NK/T-cell lymphoma, the Epstein-Barr virus (EBV) is detected inside the tumour cells in almost every case. This is so consistent that pathologists use an EBV test called EBER in-situ hybridisation as a key part of confirming the diagnosis — a positive result strongly supports it, and a negative result should make doctors reconsider. (Source: WHO classification of lymphoid tumours, as referenced in NCCN and ESMO NK/T-cell lymphoma guidelines.)
Because it starts in and around the nose, the early symptoms of nasal NK/T-cell lymphoma often look exactly like a stubborn sinus infection — which is why it is frequently diagnosed late. Warning signs to take seriously include:
Most nasal symptoms are caused by ordinary infections, not lymphoma. But a midline facial lesion or blocked nose that fails to heal over several weeks — especially with tissue destruction — should always be biopsied rather than treated repeatedly as infection. Speak to a CION specialist if this describes you.
This is a rare lymphoma that needs a coordinated, specialist approach — the right pathology, the right sequencing of radiation and drug therapy, and a team that knows how differently it behaves.
Accurate diagnosis hinges on expert haematopathology and EBV (EBER) testing on the biopsy. CION arranges immunohistochemistry and EBV in-situ hybridisation as standard, so the diagnosis is confirmed correctly before treatment begins.
Early-stage nasal disease is radiosensitive, so radiation is central. CION delivers precision IMRT directly, shaping the dose to the nasal and midline region while protecting the eyes, brain and salivary glands.
Because this lymphoma resists several standard drug classes, chemotherapy must be chosen specifically. CION's medical oncology team delivers systemic therapy directly and coordinates stem-cell transplant referral through accredited partners when needed.
Every case is reviewed by a multidisciplinary tumour board. See our best lymphoma doctors in Hyderabad and request a free written second opinion on your reports.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just received a diagnosis, worried about a nasal lesion that won't heal, or need a second opinion before treatment? CION's lymphoma team is here.
Reaching a confident diagnosis takes a step-by-step pathway. Because the tumour destroys tissue and mimics infection, this is one lymphoma where getting the pathology right is especially important. CION delivers biopsy coordination, specialist pathology, staging scans and molecular testing directly.
A tissue biopsy read by a haematopathologist confirms the diagnosis. Because the affected area is often ulcerated and necrotic, more than one biopsy may be needed to obtain viable tumour cells. Under the microscope, the cells characteristically invade and destroy small blood vessels — a hallmark of this lymphoma.
Special stains identify NK/T-cell markers, and crucially the tumour is tested for the Epstein-Barr virus using EBER in-situ hybridisation. A positive EBV result is present in nearly every case and is central to confirming the diagnosis. These are testing concepts, and naming them helps you understand your pathology report.
Once diagnosed, a PET-CT scan maps how far the disease extends, and a bone-marrow examination checks for spread. Blood EBV-DNA levels may also be measured and can help track response later. Staging follows NCCN and ESMO standards, and CION performs these assessments directly.
Treatment is driven by the stage of disease and differs from the approach used for most other lymphomas. Every case is reviewed by CION's multidisciplinary tumour board before the plan is set. The main building blocks are:
Early-stage nasal NK/T-cell lymphoma is notably radiosensitive, so radiation to the affected nasal and midline region is a cornerstone of curative-intent treatment for localised disease. CION delivers precision IMRT in-house, shaping the dose to the tumour while sparing the eyes, brain and salivary glands. For localised disease, radiation is usually combined with chemotherapy rather than used alone.
This lymphoma resists several standard chemotherapy drug classes, linked to a protein the cells use to pump drugs out. So the systemic treatment relies on non-cross-resistant chemotherapy approaches that are not affected by that mechanism. CION's medical oncology team delivers systemic therapy directly. Because the specific regimens are specialised, we route detailed drug-protocol questions to our Lymphoma Treatment in Hyderabad page.
For selected patients — particularly those with advanced disease or after a response to initial treatment — a stem-cell transplant may be recommended to consolidate remission. Transplant is coordinated through an accredited partner facility, not delivered in-house. CION manages the referral, the surrounding chemotherapy and all follow-on care.
Because the disease affects the face and can cause nutritional and dental challenges, supportive care matters. CION manages nutrition, pain, infection prevention and rehabilitation in-house, alongside a structured survivorship and monitoring plan — including tracking blood EBV-DNA where relevant.
The outlook for extranodal NK/T-cell lymphoma depends heavily on the stage at diagnosis, how quickly treatment starts, and the response to radiation and chemotherapy. Localised nasal disease treated promptly with modern radiation-based approaches can achieve meaningful long-term remission in many patients; advanced or relapsed disease is more challenging.
To keep expectations honest: published series report survival of roughly 80–90% for Hodgkin lymphoma and around 60–70% for diffuse large B-cell lymphoma — but NK/T-cell lymphoma is a separate, rarer entity, and those figures should not be read across to it. Outcomes vary considerably from person to person, which is why an individualised assessment matters more than any published average.
A second opinion is especially valuable if EBV testing has not been done, if the diagnosis or subtype is uncertain, or before committing to a treatment path. CION offers a dedicated, free written second-opinion service — a plan built around healing, with transparent costs explained up front. Request your free second opinion or call 18002028726. You can also explore our best lymphoma hospital in Hyderabad page.
Extranodal NK/T-cell lymphoma belongs to the wider T-cell lymphoma family. If you are researching related conditions, these distinct subtypes are managed differently and may be relevant:
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if EBV testing has not yet been arranged on your biopsy.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Extranodal NK/T-cell lymphoma is an uncommon and aggressive form of non-Hodgkin lymphoma that arises from natural killer (NK) cells, or less often from T-cells. The "nasal type" is the most common presentation and centres on the nose, sinuses and midline of the face, though it can also appear in the skin, gut and other sites. It is a distinct entity within the T-cell lymphoma family and is strongly linked to the Epstein-Barr virus (EBV). Because it behaves differently from more common lymphomas, it is diagnosed and managed by a specialist team. Learn more about the wider disease on our lymphoma hub.
The earliest symptoms often mimic a stubborn sinus infection: a persistently blocked nose, nosebleeds, facial swelling around the nose or cheek, and a nasal discharge that does not clear with antibiotics. As it progresses, it can cause a destructive ulcer or hole in the midline of the palate or nose, facial pain, and swelling around the eye. Because these signs look like ordinary ENT problems, nasal lymphoma is frequently diagnosed late. Any midline facial lesion or nasal blockage that fails to heal over several weeks — especially with tissue destruction — should prompt a biopsy. If you have these symptoms, speak to a CION specialist for an urgent review.
Diagnosis rests on a tissue biopsy read by a haematopathologist. Because the tumour destroys tissue, several biopsies may be needed to get a diagnostic sample. Under the microscope the cells show a characteristic pattern of invading and destroying small blood vessels. Immunohistochemistry typically shows NK/T-cell markers and, importantly, EBV is detected in the tumour cells using a test called EBER in-situ hybridisation — a near-constant feature that helps confirm the diagnosis. Staging uses a PET-CT scan and a bone-marrow examination, and blood EBV-DNA levels may be measured. CION delivers biopsy coordination, pathology review, PET-CT and bone-marrow assessment directly, following NCCN and ESMO diagnostic standards.
It is closely related but classified as its own distinct entity. Most cases arise from natural killer (NK) cells rather than true T-cells, though a minority are genuinely of T-cell origin — which is why the full name is "NK/T-cell". It sits within the broader T-cell lymphoma group in the WHO classification but is separated out because of its unique link to EBV, its midline facial location, and its distinct treatment approach. This differs from other T-cell subtypes such as peripheral T-cell lymphoma or anaplastic large cell lymphoma, each of which is managed differently.
Treatment is stage-driven and differs from most other lymphomas. For early-stage nasal disease confined to one region, radiation therapy (IMRT) is central and is often combined with chemotherapy that is chosen specifically because this lymphoma resists standard drug classes. For more advanced or widespread disease, combination chemotherapy leads, and selected patients may be referred for a stem-cell transplant through an accredited partner facility. CION delivers the radiation, chemotherapy, supportive care and monitoring directly and coordinates transplant referral. Because regimens are specialised, we route specific drug-protocol questions to our Lymphoma Treatment in Hyderabad page. Every case is reviewed by a multidisciplinary tumour board first.
Unlike many lymphomas that respond mainly to drug therapy, early-stage nasal NK/T-cell lymphoma is notably radiosensitive — it responds well to radiation. Because the tumour cells can resist several standard chemotherapy drug classes (linked to a protein they express that pumps drugs out of the cell), radiation to the affected nasal and midline region is a cornerstone of curative-intent treatment for localised disease, per NCCN and ESMO guidance. CION delivers precision IMRT in-house, shaping the dose to the tumour while protecting the eyes, brain and salivary glands. For localised disease, radiation is usually paired with a non-cross-resistant chemotherapy approach rather than used alone.
The outlook varies widely and depends heavily on stage at diagnosis, how quickly treatment starts, and the response to radiation and chemotherapy. Localised nasal disease treated promptly with modern radiation-based approaches can achieve meaningful long-term remission in many patients, whereas advanced or relapsed disease is harder to control. For context, published series report Hodgkin lymphoma survival around 80–90% and diffuse large B-cell lymphoma around 60–70%, but NK/T-cell lymphoma is a separate, rarer entity and these figures do not apply directly to it. All outcomes vary by individual. For a personalised assessment, request a free second opinion and see our lymphoma hospital in Hyderabad page.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.